Cardiac-specific deletion of desmoglein 2 in mice triggered early inflammatory responses at 2 weeks, preceding severe cardiac fibrosis and a significant decline in ejection fraction by 10 weeks.
Absolute Event Rate: 43.62% vs 63.7%
p-value: p=<0.0001
Abstract The study of a desmoglein 2 murine model of arrhythmogenic cardiomyopathy revealed cardiac inflammation as a key early event leading to fibrosis. Arrhythmogenic cardiomyopathy (AC) is an inherited heart muscle disorder leading to ventricular arrhythmias and heart failure due to abnormalities in the cardiac desmosome. We examined how loss of desmoglein 2 ( Dsg2 ) in the young murine heart leads to development of AC. Apoptosis was an early cellular phenotype, and RNA sequencing analysis revealed early activation of inflammatory-associated pathways in Dsg2 -null ( Dsg2 −/− ) hearts at postnatal day 14 (2 weeks) that were absent in the fibrotic heart of adult mice (10 weeks). This included upregulation of iRhom2/ADAM17 and its associated pro-inflammatory cytokines and receptors such as TNFα, IL6R and IL-6. Furthermore, genes linked to specific macrophage populations were also upregulated. This suggests cardiomyocyte stress triggers an early immune response to clear apoptotic cells allowing tissue remodelling later on in the fibrotic heart. Our analysis at the early disease stage suggests cardiac inflammation is an important response and may be one of the mechanisms responsible for AC disease progression.
NG et al. (Thu,) conducted a other in Arrhythmogenic cardiomyopathy. Cardiac-specific deletion of Dsg2 (Dsg2-/-) vs. Wild-type Dsg2+/+ and heterozygous Dsg2+/- mice was evaluated on Ejection fraction at 10 weeks (p=<0.0001). Cardiac-specific deletion of desmoglein 2 in mice triggered early inflammatory responses at 2 weeks, preceding severe cardiac fibrosis and a significant decline in ejection fraction by 10 weeks.